Lonza Grp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Lonza Group AG (LONN)
Lonza Group AG stock price live, this page displays SIX LONN stock exchange data. View the LONN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Lonza Group AG real time stock price chart below.
What Is the Lonza Group AG Stock Price Today?
The Lonza Group AG stock price today is 607.20.
What Is the Stock Symbol for Lonza Group AG?
The stock symbol for Lonza Group AG is ""LONN.""
What Stock Exchange Does Lonza Group AG Trade On?
Lonza Group AG is listed and trades on the Switzerland stock exchange.
Is Lonza Group AG a Good Stock to Buy?
Determining whether Lonza Group AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LONN quote. (ISIN: CH0013841017)
What Is the Lonza Group AG Stock Price Today?
The Lonza Group AG stock price today is 607.20.
What Is the Stock Symbol for Lonza Group AG?
The stock symbol for Lonza Group AG is ""LONN.""
What Stock Exchange Does Lonza Group AG Trade On?
Lonza Group AG is listed and trades on the Switzerland stock exchange.
Is Lonza Group AG a Good Stock to Buy?
Determining whether Lonza Group AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LONN quote. (ISIN: CH0013841017)
607.20
+1.40(+0.23%)
Closed·
Fair Value
An estimate of a Lonza Group AG's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
607.00
613.40
52 wk Range
589.40
625.40
LONN Scorecard
Full Analysis
Management has been aggressively buying back shares
LONN is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Lonza Group AG's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
607.00613.40
52 wk Range
589.40625.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.70%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.70%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
LONN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Lonza Group AG's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
- Lonza Grp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Lonza Grp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Lonza Grp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Lonza Grp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Lonza Grp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Lonza Group AG Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. Its Small Molecules segment provides integrated development and manufacturing services for small molecule drug substances and their intermediates. This segment also supports customers across aspects of design, development, and manufacturing, such as particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. Its Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Compare LONN to Peers and Sector
Metrics to compare | LONN | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipLONNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 54.6x | 27.1x | −0.5x | |
PEG Ratio | 1.77 | 0.01 | 0.00 | |
Price/Book | 4.6x | 2.8x | 2.6x | |
Price / LTM Sales | 5.6x | 4.0x | 3.2x | |
Upside (Analyst Target) | - | 21.9% | 41.4% | |
Fair Value Upside | Unlock | 13.8% | 6.0% | Unlock |
Earnings
Latest Release
Jul 23, 2025
EPS / Forecast
6.07 / --
Revenue / Forecast
3.58B / --
People Also Watch
FAQ
What Stock Exchange Does Lonza Group AG Trade On?
Lonza Group AG is listed and trades on the Vienna Stock Exchange stock exchange.
What Is the Stock Symbol for Lonza Group AG?
The stock symbol for Lonza Group AG is "LONN."
What Is the Lonza Group AG Market Cap?
As of today, Lonza Group AG market cap is 42.91B.
What Is Lonza Group AG's Earnings Per Share (TTM)?
The Lonza Group AG EPS (TTM) is 10.39.
From a Technical Analysis Perspective, Is LONN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Lonza Group AG Stock Split?
Lonza Group AG has split 0 times.
How Many Employees Does Lonza Group AG Have?
Lonza Group AG has 19299 employees.
What is the current trading status of Lonza Group AG (LONN)?
As of 27 Jul 2025, Lonza Group AG (LONN) is trading at a price of 607.20, with a previous close of 605.80. The stock has fluctuated within a day range of 607.00 to 613.40, while its 52-week range spans from 589.40 to 625.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.